Related Experiment Video
Updated: Jun 9, 2025

28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
33.4K
Validation Strategy for Pulmonary Vein Isolation in Patients With Paroxysmal Atrial Fibrillation in Long-Term
Xinyu Li1, Houdeng Yu1, Shihuang Lai1
1Division of Cardiology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Cardiology Research and Practice
|October 24, 2024
Summary
Rigorous validation for pulmonary vein isolation (PVI) in paroxysmal atrial fibrillation (PAF) detects more dormant conduction but does not improve long-term outcomes compared to loose validation. Both strategies show similar recurrence rates after addressing reconnections.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Limited data exists comparing loose versus rigorous validation strategies for pulmonary vein isolation (PVI) in paroxysmal atrial fibrillation (PAF).
- This study prospectively evaluates the effectiveness of these validation methods in patients with PAF maintaining sinus rhythm.
Purpose of the Study:
- To compare the effectiveness of loose versus rigorous validation strategies for PVI in patients with PAF.
- To assess the impact of validation strategies on the detection of dormant conduction and long-term recurrence rates.
Main Methods:
- 117 patients with PAF were randomized to either loose (n=59) or rigorous (n=58) validation post-PVI.
- Loose validation used adenosine and isoproterenol; rigorous validation additionally employed Lasso catheter for complete pulmonary vein (PV) potential absence.
- Dormant conduction was ablated until all reconnections were eliminated.
Main Results:
- Rigorous validation group had longer procedure times (161.3 min vs. 142.5 min, p=0.03).
- Dormant PV reconnections were detected more frequently in the rigorous group (69.0% vs. 37.3%, p=0.001).
- Despite this, 1.3-year postablation recurrence rates were similar between groups (79.2% vs. 83.6%, p=0.67).
Conclusions:
- Rigorous validation identifies dormant conduction in over two-thirds of PAF patients undergoing PVI.
- However, rigorous validation and additional ablation do not enhance long-term outcomes when electrophysiological and pharmacological confirmation protocols are used.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
3
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
3
Dysrhythmias IV: Characteristics of Bradyarrhythmias
3
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
3

